Literature DB >> 9222054

Factors affecting development of rifampicin resistance in biofilm-producing Staphylococcus epidermidis.

E Svensson1, H Hanberger, M Nilsson, L E Nilsson.   

Abstract

Selection and regrowth of variants resistant to 0.016-32 mg/L of rifampicin, which were present at a frequency of 10(-7) in the initial inoculum, were seen when large inocula (> 10(5) cfu/mL) of Staphylococcus epidermidis ATCC 35984 were incubated with the drug. Conventional MIC determinations using approximately 10(5) cfu/mL did not detect the resistant variants. Larger inocula increased the MIC by > 8000-fold. Population analysis showed that rifampicin concentrations above the MIC (measured at an inoculum of approximately 10(5) cfu/mL) select highly resistant variants (MIC > 256 mg/L) when large inocula (> or = 10(5) cfu/mL) were incubated with rifampicin. The resistant variants were stable through ten passages. It was not possible to prevent regrowth of the resistant variants by increasing the rifampicin concentration further. At subinhibitory concentrations there was no development of rifampicin resistance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9222054     DOI: 10.1093/jac/39.6.817

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  Unpredictable effects of rifampin as an adjunctive agent in elimination of rifampin-susceptible and -resistant Staphylococcus aureus strains grown in biofilms.

Authors:  Sander Croes; Patrick S Beisser; Cees Neef; Cathrien A Bruggeman; Ellen E Stobberingh
Journal:  Antimicrob Agents Chemother       Date:  2010-07-06       Impact factor: 5.191

2.  Penetration of rifampin through Staphylococcus epidermidis biofilms.

Authors:  Zhilan Zheng; Philip S Stewart
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

3.  Peri-implant tissue is an important niche for Staphylococcus epidermidis in experimental biomaterial-associated infection in mice.

Authors:  Corine A N Broekhuizen; Leonie de Boer; Kim Schipper; Christopher D Jones; Shan Quadir; Roger G Feldman; Jacob Dankert; Christina M J E Vandenbroucke-Grauls; Jan J Weening; Sebastian A J Zaat
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

Review 4.  Material properties of biofilms-a review of methods for understanding permeability and mechanics.

Authors:  Nicole Billings; Alona Birjiniuk; Tahoura S Samad; Patrick S Doyle; Katharina Ribbeck
Journal:  Rep Prog Phys       Date:  2015-02-26

Review 5.  [Antibiotic strategies in trauma surgery : Treatment of implant-associated infections].

Authors:  Susanne Feihl; Nora Renz; Michael Schütz; Michael Müller
Journal:  Unfallchirurg       Date:  2017-06       Impact factor: 1.000

6.  Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection.

Authors:  Jagath L Kadurugamuwa; Lin V Sin; Jun Yu; Kevin P Francis; Richard Kimura; Tony Purchio; Pamela R Contag
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

7.  Reduction of Thrombosis and Bacterial Infection via Controlled Nitric Oxide (NO) Release from S-Nitroso-N-acetylpenicillamine (SNAP) Impregnated CarboSil Intravascular Catheters.

Authors:  Yaqi Wo; Elizabeth J Brisbois; Jianfeng Wu; Zi Li; Terry C Major; Azmath Mohammed; Xianglong Wang; Alessandro Colletta; Joseph L Bull; Adam J Matzger; Chuanwu Xi; Robert H Bartlett; Mark E Meyerhoff
Journal:  ACS Biomater Sci Eng       Date:  2017-01-22

8.  If, When, and How to Use Rifampin in Acute Staphylococcal Periprosthetic Joint Infections, a Multicentre Observational Study.

Authors:  Mark Beldman; Claudia Löwik; Alex Soriano; Laila Albiach; Wierd P Zijlstra; Bas A S Knobben; Paul Jutte; Ricardo Sousa; André Carvalho; Karan Goswami; Javad Parvizi; Katherine A Belden; Marjan Wouthuyzen-Bakker
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 20.999

9.  Open wounds and rifampicin therapy are associated with rifampicin resistance among staphylococcal vascular graft/endograft infections.

Authors:  Yau Kei Stefan Leung; Bruno Ledergerber; Nadia Eberhard; Carlos A Mestres; Zoran Rancic; Alexander Zimmermann; Reinhard Zbinden; Silvio D Brugger; Annelies S Zinkernagel; Barbara Hasse
Journal:  JAC Antimicrob Resist       Date:  2021-03-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.